Fieldpoint Private Securities’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Fieldpoint Private Securities’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-22	Closed	-$2K	–	1738
2022 Q1	$2K	Sell	22 -127	-85%	-$11.7K	﹤0.01%	1522
2021 Q4	$17K	Sell	149 -93	-38%	-$11.2K	﹤0.01%	926
2021 Q3	$30K	Hold	242	–	–	0.01%	707
2021 Q2	$31K	Sell	242 -8	-3%	-$1.05K	0.01%	680
2021 Q1	$34K	Sell	250 -14,194	-98%	-$2.13M	0.01%	652
2020 Q4	$2.03M	Buy	14,444 +315	+2%	+$40.3K	0.46%	58
2020 Q3	$1.57M	Buy	14,129 +1,564	+12%	+$175K	0.46%	61
2020 Q2	$1.41M	Buy	12,565 +6,666	+113%	+$657K	0.47%	61
2020 Q1	$457K	Buy	5,899 +1,324	+29%	+$117K	0.18%	143
2019 Q4	$435K	Buy	4,575 +315	+7%	+$27.2K	0.13%	171
2019 Q3	$325K	Sell	4,260 -400	-9%	-$33.2K	0.12%	176
2019 Q2	$409K	Hold	4,660	–	–	0.13%	167
2019 Q1	$422K	Hold	4,660	–	–	0.17%	138
2018 Q4	$334K	Sell	4,660 -125	-3%	-$10.1K	0.15%	152
2018 Q3	$459K	Hold	4,785	–	–	0.17%	135
2018 Q2	$455K	Hold	4,785	–	–	0.17%	132
2018 Q1	$420K	Sell	4,785 -1,077	-18%	-$98.3K	0.19%	115
2017 Q4	$498K	Hold	5,862	–	–	0.26%	98
2017 Q3	$507K	Buy	5,862 +977	+20%	+$78.3K	0.22%	114
2017 Q2	$377K	Hold	4,885	–	–	0.26%	54
2017 Q1	$339K	Buy	+4,885	New	+$328K	0.26%	79

Other funds holding XBI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Fieldpoint Private Securities's XBI Position: Q2 2022 in Review

Fieldpoint Private Securities sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2022, closing a stake of 22 shares — an estimated $2K sold.

Fieldpoint Private Securities first reported a position in XBI in Q1 2017 and held it in 21 quarters. The position peaked at $2.03M in Q4 2020. 704 funds tracked by Wall St. Rank hold XBI as of Q2 2022.

Fieldpoint Private Securities reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2022 after selling out during the quarter.
Fieldpoint Private Securities sold 22 State Street SPDR S&P Biotech ETF shares in Q2 2022, an estimated $2K.
Fieldpoint Private Securities first reported a position in State Street SPDR S&P Biotech ETF in Q1 2017 and held it in 21 quarters.
Fieldpoint Private Securities's State Street SPDR S&P Biotech ETF position peaked at $2.03M in Q4 2020.
704 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.